Leap Therapeutics focuses on developing DKN-01 ... LPTX presents us with an interesting near-term opportunity. The market clearly has little to no confidence that the DKN-01 program is going ...

United Therapeutics Corp. (NASDAQ: UTHR) has acquired a vacant lot near its Silver Spring headquarters, part of a larger agreement with Montgomery County tied to the company’s local expansion.

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones. Pfizer’s decision sent ...

Outlook Therapeutics (NASDAQ:OTLK), a biopharmaceutical company that focuses on retinal diseases saw its stock price upped 18.24% on Friday after its financial results for fiscal years 2024 ...

Summit Therapeutics' leading candidate is a highly promising cancer medicine. This drug performed better than the market leader in an important indication. Summit Therapeutics should make ...

SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics ... granted NX-5948 PRIME designation for the treatment of adult patients with relapsed or refractory CLL/SLL after at least ...

A turbulent month at Applied Therapeutics is being capped off with the departure of CEO and chair Shoshana Shendelman, Ph.D., mere days after she and the company were named in a proposed class ...

Drone sightings across the northeast skies have been reported with some spotted near or over airport spaces. The Transportation Security Administration (TSA) expects nearly 40 million people to ...

Merck just closed a deal to develop a weight-loss drug. The market appears to think Viking Therapeutics is threatened by that data. There's little reason to write off Viking here. First ...